Review
Copyright ©The Author(s) 2021.
World J Clin Oncol. Nov 24, 2021; 12(11): 983-999
Published online Nov 24, 2021. doi: 10.5306/wjco.v12.i11.983
Table 2 Ongoing clinical trials of radiotherapy and immune checkpoint inhibitors combination in locally advanced stage non-small-cell lung cancer in the neoadjuvant setting
Ref.
Phase
Design
No.ofpatients
Tumor stage
RT
ICI agent
Sequence
Status
CASE4516, NCT02987998[72]1Neoadjuvant CRT (CDDP-etoposide) + ICI followed by surgery and consolidative ICI20Resectable IIIA45 Gy/25 fx (1.8 Gy/fx)Pembroli zumabConcomitant (neoadjuvant) + adjuvant ICIActive, not recruiting
NCT03237377[73]2Neoadjuvant RT-ICI followed by surgery +/-adjuvant CT32Resectable IIIA45 Gy/25 fx (1.8-2 Gy/fx)Durvalumab ± tremelimumabConcomitant(neoadjuvant)Recruiting
NCT04245514, SAKK 16/18[74]2 3 RT armsNeoadjuvant RT-ICI followed by surgery90Resectable IIIARandomized 1:1:1; A: 20 × 2 Gy; B: 5 × 5 Gy; C: 3 × 8 Gy (non -consecutive days)DurvalumabConcomitant (neoadjuvant)Recruiting
INCREASE, NL8435[75]2 single armNeoadjuvant CRT (platinum doublet) + ICI followed by surgery29Resectable IIB-III (T3-4 N0-1)50 Gy/25 fxIpilimumab + NivolumabConcomitant (neoadjuvant)Recruiting
NCT02904954[76]2 randomizedNeoadjuvant ICI +/- SBRT followed by surgery and adjuvant maintenance ICI60Resectable I-IIIASBRT 24 Gy/3 fxDurvalumabConcomitantneoadjuvant + adjuvant ICIActive, not recruiting
NCT03871153[77]2 single armNeoadjuvant CRT (Carbo-taxol) + ICI followed by surgery and adjuvant ICI25Resectable IIIA N245-61.2 Gy (25-34 fx a 1.8-2 Gy/fx)DurvalumabConcomitant (neoadjuvant) + adjuvant ICIRecruiting
CHIO3, NCT04062708[78]2single armConcomitant neoadjuvant CT (platinum doublet + ICI followed by surgery + adjuvant RT followed by ICI55Resectable IIIA-IIIB 54 GyDurvalumabConcomitant CT-ICI (neoadjuvant) + adjuvant ICI (after adjuvant RT)Not yet recruiting
NCT03102242[79]2singlearmInduction ICI followed by definitive CRT (Carbo-Taxol followed by consolidation CT-ICI63Unresectable IIIA-IIIB 60 Gy/30 fxAtezolizumabNeoadjuvant + consolidative ICIActive, notrecruiting
NCT02572843[80]2Neoadjuvant CT (platinum + docetaxel) + ICI followed by surgery +/-RT + ICI68Resectable IIIA N2Convenional RT if R1-R2 and before adjuvant ICIDurvalumabNeoadjuvant + adjuvantActive, not recruiting